Laddar populära aktier...
Redeye comments on MGI’s Q4 2023 report, which came in better than expected.
Mangold uppdaterar sin syn på sensorteknikbolaget JonDeTech Sensors (JonDeTech).
Redeye provides an update in relation to ISAB’s Q4 2023 report.
Net sales and adjusted EBITDA were above LSEG Data & Analytics consensus for Q4.
Sales -6% due to Enedo despite high material sales in Inission comps EBITA margin 5.
Avslutar året starkt Nettoomsättningen i kvartalet uppgick till 40,4 mkr, vilket motsvarar en tillvä...
Redeye comments on Physitrack’s Q4 figures, which slightly missed our expectations on topline.
Redeye comments on Fluoguide’s Q4 2023 report, with the company having recently communicated a strat...
Björn Borg (“Björn Borg”, the Company” or the Group) is a well-established and renowned company with...
Fortsatt utmanande kvartal med få ljusglimtar Omsättningen i kvartalet uppgick till EUR 9,9m, vilket...
Redeye reviews the case of Alzecure after the Q4 report, which offered no surprises, and continues t...
Redeye comments on Scibase’s new partnership within the Barrier field.
Spotlight Group redovisade en nettoomsättning över förväntan i kv4 2023, vilket är positivt givet at...
Sales36.0m (-3% vs. ABGSCe), adj. EBIT 15.6m (+1% vs.
Redeye makes minor upwards adjustments to its fair value range following Lifecare’s year-end report ...